Intelligent Acceleration
for Drug Development

Modern. Innovative. Integrated.

Who We Are

InCevo

InCevo is a modern, innovation-focused contract research organization (CRO) specializing in oncology and hematology drug development. Our firm partners with biopharma teams to lead programs and deliver expert guidance, planning, and oversight from discovery through regulatory approval.

We bring deep expertise across both biologics and small molecule development, including monoclonal and multi-specific antibodies, Immune cell engagers, antibody-drug conjugates (ADCs), next-generation protein degraders and other modalities.

We operate as a lean, high-impact partner, focusing on the decisions that matter most — the ones that define timelines, reduce risk, and accelerate value.

Contact Us >>
rnresearchAbout2a

Innovative Strategies & Leadership

We provide strategic leadership and integrated development planning to guide programs & portfolio from early discovery through approval. Our seasoned global program leaders (GPLs) bring deep cross-functional experience, driving innovation through data-driven decisions, risk-informed strategies, and agile execution. We partner closely with biopharma teams to lead with clarity, align stakeholders, and deliver high-impact results across the development lifecycle.

rnresearchBGservice1
rnresearchBGservice1a

Expertise Across the Drug Development Cycle

We offer end-to-end strategic solutions across every phase of drug development. Our cross-functional expertise spans clinical development, regulatory strategy, translational science, clinical pharmacology, modeling & simulation, CMC, biostatistics and advanced data analytics. With integrated knowledge across these disciplines, we help biopharma teams de-risk decisions, streamline execution, and advance programs with confidence and clarity.

Business Development & Due Diligence

We provide strategic and scientific support to help biopharma clients evaluate BD opportunities with confidence and clarity. We assist in scientific reviews, assess pipeline & portfolio fit, benchmark competitive positioning, and evaluate regulatory/development risks.

rnresearchBGservice3

Services

click on a service to read more

Program Leadership
and Portfolio Strategy

Preclinical Development
Strategy

Clinical Development
Strategy

Quantitative and
Translational Strategy

RWD/RWE and
AI-Driven Insights

Business Development
& Due Diligence

LogologoInCevoW

At InCevo, we are redefining drug development through the seamless integration of strategic insight, scientific expertise, and advanced technology. From early discovery to regulatory approval, we offer end-to-end strategic solutions that accelerate timelines, reduce complexity, and drive meaningful impact.

Contact Us >>